- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
BALAXI PHARMACEUTICALS LIMITED — Important, 28-05-2026: Updates
28-05-2026 | 07:42 pm
28-05-2026 | 07:42 pm
Balaxi Pharma secured a manufacturing license for its Jadcherla plant, readying for commercial launch of Paracetamol & Piroxicam, with 40 more products in pipeline and WHO-GMP certification underway. FY26 consolidated revenue was 270.17 Cr, with net profit at 1.42 Cr.
No comments yet. Be the first to comment!